{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:58:05Z","timestamp":1787007485683,"version":"build-2736575974"},"reference-count":49,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72074123"],"award-info":[{"award-number":["72074123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiology"],"published-print":{"date-parts":[[2025,2,11]]},"DOI":"10.1080\/17460913.2024.2423530","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T05:53:19Z","timestamp":1731909199000},"page":"213-225","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Economic evaluation of treating invasive aspergillosis with isavuconazole, posaconazole and voriconazole in China"],"prefix":"10.1080","volume":"20","author":[{"given":"Qiang","family":"Liu","sequence":"first","affiliation":[{"name":"Center for Global Health","place":["Nanjing, China"]},{"name":"School of Public Health","place":["Nanjing, China"]},{"name":"Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Health Economics","place":["Nanjing, China"]},{"name":"China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunming","family":"Xiao","sequence":"additional","affiliation":[{"name":"School of Public Health","place":["Shanghai, China"]},{"name":"Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science & Pharmacoeconomics","place":["Nanjing, China"]},{"name":"School of Pharmacy","place":["Nanjing, China"]},{"name":"Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yintao","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Global Health","place":["Nanjing, China"]},{"name":"School of Public Health","place":["Nanjing, China"]},{"name":"Nanjing Medical University","place":["Nanjing, China"]},{"name":"Department of Drug Clinical Trial Institution","place":["Fuzhou, China"]},{"name":"Fujian Medical University Cancer Hospital","place":["Fuzhou, China"]},{"name":"Fujian Provincial Cancer Hospital","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science & Pharmacoeconomics","place":["Nanjing, China"]},{"name":"School of Pharmacy","place":["Nanjing, China"]},{"name":"Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-8061","authenticated-orcid":false,"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Global Health","place":["Nanjing, China"]},{"name":"School of Public Health","place":["Nanjing, China"]},{"name":"Nanjing Medical University","place":["Nanjing, China"]},{"name":"Department of Pharmaceutical Regulatory Science & Pharmacoeconomics","place":["Nanjing, China"]},{"name":"School of Pharmacy","place":["Nanjing, China"]},{"name":"Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-017-0601-0"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104616"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760200430"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30243-8"},{"key":"e_1_3_3_11_1","unstructured":"Fungal Disease Frequencyg [Internet]. Switzerland: GAFFI [cited 2024 Oct 10]. Available from: https:\/\/gaffi.org\/why\/fungal-disease-frequency\/"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403674"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0093"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2009.02.005"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30303-1"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir866"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.20121945"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/2049-6958-9-1"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.12290\/xyxzz.2022-0654"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz573"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13089"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1894902"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2021.03.001"},{"issue":"3","key":"e_1_3_3_24_1","first-page":"5","article-title":"Pharmacoeconomic evaluation of posaconazole in preventing invasive fungal disease in patients with neutropenia","volume":"17","author":"Liping D","year":"2019","unstructured":"Liping D, Chen Y, Yongen L, et al. Pharmacoeconomic evaluation of posaconazole in preventing invasive fungal disease in patients with neutropenia. Clinical Medication Journal. 2019;17(3):5. Chinese.","journal-title":"Clinical Medication Journal."},{"issue":"1","key":"e_1_3_3_25_1","first-page":"27","article-title":"Diagnosis and treatment status and economic burden of invasive aspergillosis patients in China","volume":"18","author":"Yongjia Z","year":"2023","unstructured":"Yongjia Z, Feng Y, Kejing T, et al. Diagnosis and treatment status and economic burden of invasive aspergillosis patients in China. China Journal of Pharmaceutical Economics. 2023;18(1):27\u201335. Chinese.","journal-title":"China Journal of Pharmaceutical Economics."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13643"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.007"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20200627-00624"},{"key":"e_1_3_3_29_1","unstructured":"China: National Medical Products Administration. The release of pending collection information for drug approval certificates on January 5 2022. [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20220105143701157.html"},{"key":"e_1_3_3_30_1","unstructured":"China: National Medical Products Administration. The release of pending collection information for drug approval certificates on June 20 2022. [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20220620141308104.html"},{"key":"e_1_3_3_31_1","unstructured":"China: National Medical Products Administration. The release of pending collection information for drug approval certificates on April 6 2022. [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20220406084341107.html"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01159-9"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00219-1"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2016.1164175"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1638789"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3683-2"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0443-1"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2021.1981862"},{"key":"e_1_3_3_39_1","unstructured":"China: National Healthcare Security Administration. National Basic Medical Insurance Work Injury Insurance and Maternity Insurance Drug Catalog (2023 Edition) [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.nhsa.gov.cn\/art\/2023\/12\/13\/art_104_11673.html"},{"key":"e_1_3_3_40_1","unstructured":"China: Pfizer China. Cresemba (Isavuconazonium Sulfate Capsules) [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.pfizermedicalinformation.cn\/products\/package-insert\/cresemba"},{"key":"e_1_3_3_41_1","unstructured":"China: Pfizer China. Cresemba (Isavuconazonium Sulfate for Injection) [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.pfizermedicalinformation.cn\/products\/package-insert\/cresemba-injection"},{"key":"e_1_3_3_42_1","unstructured":"China: MSD China. Noxafil (Posaconazole Enteric-coated Tablets & Posaconazole Injection) [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.msdchina.com.cn\/Product\/"},{"key":"e_1_3_3_43_1","unstructured":"China: Pfizer China. Vfend (Voriconazole Tablets) [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.pfizermedicalinformation.cn\/products\/package-insert\/vfend-tablets"},{"key":"e_1_3_3_44_1","unstructured":"China: Pfizer China. Vfend (Voriconazole for Injection) [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.pfizermedicalinformation.cn\/products\/package-insert\/vfend-injection"},{"key":"e_1_3_3_45_1","unstructured":"Netherlands: Durgis. Aggregate Data Drug Information System [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/addis.drugis.org\/"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-2727.2016.09.0018"},{"key":"e_1_3_3_47_1","unstructured":"China: National Health Commission. 2020 China Health Statistical Yearbook [Internet]. [cited 2024 Oct 10]. Available from: http:\/\/www.nhc.gov.cn\/mohwsbwstjxxzx\/tjtjnj\/202112\/dcd39654d66c4e6abf4d7b1389becd01.shtml"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2018-0119"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1502659"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1292162"},{"key":"e_1_3_3_51_1","unstructured":"China: National Healthcare Security Administration. The bidding rules for non-exclusive medicines [Internet]. [cited 2024 Oct 10]. Available from: https:\/\/www.nhsa.gov.cn\/module\/download\/downfile.jsp?classid=0&filename=e0ab230491274cb2be585a47dabfd87d.pdf"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460913.2024.2423530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:17:12Z","timestamp":1738905432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460913.2024.2423530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2,11]]}},"alternative-id":["10.1080\/17460913.2024.2423530"],"URL":"https:\/\/doi.org\/10.1080\/17460913.2024.2423530","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}